Harmony Biosciences Holdings, Inc.
- Last sale
- Nov 12, 2026 · -1.24%
- Market cap
- $1.99B
- 58.72M shares
- Filings
- 461
Q3 2026+21.5% FY25 yoy
Q3 2026+9.1% FY25 yoy
Q3 2026+9.2% FY25 yoy
FY 2025derived+59.1% FY25 yoy
Q3 2026+8.0% FY25 yoy
Q3 2026+66.1% FY25 yoy
- $1.99B
- 11.1×
- 2.0×
- 1.9×
- —
- —
Twelve months to Sep 30, 2026 · derived
Price
Nov 12, 2026 · IEX last sale
IEX last saleClose of recordAs traded
Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.
Financials
Revenue
| Period | Ended | Value | Kind | Source trail |
|---|---|---|---|---|
| FY 2025 | 2025-12-31 | $868,453,000 | reported | |
| FY 2024 | 2024-12-31 | $714,734,000 | reported | |
| FY 2023 | 2023-12-31 | $582,022,000 | reported | |
| FY 2022 | 2022-12-31 | $437,855,000 | reported | |
| FY 2021 | 2021-12-31 | $305,440,000 | reported | |
| FY 2020 | 2020-12-31 | $159,742,000 | reported | |
| FY 2019 | 2019-12-31 | $5,995,000 | reported |
Capital returns
| Fiscal year | Dividends | Buybacks | Total | Per share | Shares | Shares · yoy | of free cash flow |
|---|---|---|---|---|---|---|---|
| FY2023 | — | $100.00M | $100.00M | — | 56.77M sh | −4.8% | 45.6% |
| FY2020 | — | $167.00K | $167.00K | — | 56.89M sh | +630.6% | — |
Pharmaceutical preparations
Harmony Biosciences Holdings, Inc. is the 39th largest of the 553 covered companies the SEC files under this code, by revenue. SIC 2834
CompanyRevenueGrowthNet marginMarket cap
LEGNLegend Biotech Corp$1.0B64.0%28.8%$3.4BMDGLMadrigal Pharmaceuticals, Inc.$958.4M432.1%30.1%$9.9BIONSIonis Pharmaceuticals Inc$943.7M33.8%40.4%$4.5BANIPANI Pharmaceuticals Inc$883.4M43.8%8.9%$1.6B
HRMYHarmony Biosciences Holdings, Inc. (this company)$868.5M21.5%18.3%$2.0B
TLXTelix Pharmaceuticals Ltd$803.8M55.6%0.9%—COLLCollegium Pharmaceutical, Inc$780.6M23.6%8.1%$776.1MCORTCorcept Therapeutics Inc$761.4M12.8%13.1%$8.1BEBSEmergent BioSolutions Inc.$742.9M28.8%7.1%$302.3MPeers are the covered companies filed under the same SIC code, then under codes that share its first three digits or its first two, nearest in revenue first. Figures are each company’s latest fiscal year as filed; market cap is at its latest price.
Harmony Biosciences Holdings, Inc. · CIK 1802665 · Engraved from SEC EDGAR